Enorama Pharma AB Balance Sheet
Enorama Pharma AB's total assets for Q4 2025 were kr8.26M, a decrease of -34.28% from the previous quarter. SE:ERMA total liabilities were kr31.71M for the fiscal quarter, a 84.17% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.